Last 12 months
Inside the activity.
2 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 15 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 29 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 31 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 2 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 17, 2022 Filed Oct 18, 2022 23:10 UTC |
Schneider EugeneEVP, Chf Clinical Develop Ofcr
|
Tax withholdingCommon Stock | 144 | $46.52 | $6,698.88 |
DisclosureSEC source: 0000874015-22-000164 · edgardoc.xml · nonDerivative · entry 2 Schneider Eugene · CIK 0001838539 · EVP, Chf Clinical Develop Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,032 F2 · kind: Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. F2 · shares: Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 23:10 UTC |
Schneider EugeneEVP, Chf Clinical Develop Ofcr
|
Exercise / conversionCommon Stock | 416 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000164 · edgardoc.xml · nonDerivative · entry 1 Schneider Eugene · CIK 0001838539 · EVP, Chf Clinical Develop Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 23:10 UTC |
Swayze EricEVP Research
|
GrantRestricted Stock Unit · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000163 · edgardoc.xml · derivative · entry 1 Swayze Eric · CIK 0001791058 · EVP Research 10b5-1 filing: Not disclosed Ownership: Indirect · by Son Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: Grant to reporting person's son of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:08 UTC |
Swayze EricEVP Research
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $46.74 | $0.00 |
DisclosureSEC source: 0000874015-22-000159 · edgardoc.xml · derivative · entry 1 Swayze Eric · CIK 0001791058 · EVP Research 10b5-1 filing: Not disclosed Ownership: Indirect · by Son Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2032-09-18 F1 · derivative.exercise_date: Grant on 9/19/2022 to reporting person's son of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 9/19/2022. 25% of the shares subject to the option will vest and become exercisable on 9/19/2023. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 23:09 UTC |
Swayze EricEVP Research
|
SaleCommon Stock | 460 | $44.55 | $20,493.00 |
DisclosureSEC source: 0000874015-22-000157 · edgardoc.xml · nonDerivative · entry 1 Swayze Eric · CIK 0001791058 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,892 F1 · kind: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. F1 · shares: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:03 UTC |
O'NEIL PATRICK R.EVP CLO & General Counsel
|
OtherCommon Stock | 108 | $28.97 | $3,128.54 |
DisclosureSEC source: 0000874015-22-000155 · edgardoc.xml · nonDerivative · entry 1 O'NEIL PATRICK R. · CIK 0001564926 · EVP CLO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,644 F1 · kind: Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2022. These shares may not be sold until February 28, 2023. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:03 UTC |
HOUGEN ELIZABETH LEVP, Finance & CFO
|
OtherCommon Stock | 202 | $28.97 | $5,851.54 |
DisclosureSEC source: 0000874015-22-000154 · edgardoc.xml · nonDerivative · entry 1 HOUGEN ELIZABETH L · CIK 0001074773 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,561 F1 · kind: Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2022. These shares may not be sold until February 28, 2023. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:03 UTC |
BENNETT C FRANKEVP, Chief Scientific Officer
|
OtherCommon Stock | 183 | $28.97 | $5,301.14 |
DisclosureSEC source: 0000874015-22-000153 · edgardoc.xml · nonDerivative · entry 1 BENNETT C FRANK · CIK 0001073387 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,416 F1 · kind: Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2022. These shares may not be sold until February 28, 2023. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 23:02 UTC |
Swayze EricEVP Research
|
SaleCommon Stock | 1 | $45.20 | $45.20 |
DisclosureSEC source: 0000874015-22-000149 · edgardoc.xml · nonDerivative · entry 1 Swayze Eric · CIK 0001791058 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,352 F1 · kind: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. F1 · shares: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
WENDER JOSEPH HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000144 · edgardoc.xml · derivative · entry 4 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F5 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F5 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
WENDER JOSEPH HDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000144 · edgardoc.xml · derivative · entry 3 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
WENDER JOSEPH HDirector
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000144 · edgardoc.xml · nonDerivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 104,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
WENDER JOSEPH HDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000144 · edgardoc.xml · nonDerivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 102,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000143 · edgardoc.xml · derivative · entry 4 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F5 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F5 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000143 · edgardoc.xml · derivative · entry 3 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000143 · edgardoc.xml · nonDerivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000143 · edgardoc.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
MUTO FREDERICK TDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000142 · edgardoc.xml · derivative · entry 5 MUTO FREDERICK T · CIK 0001181560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F5 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F5 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
MUTO FREDERICK TDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000142 · edgardoc.xml · derivative · entry 4 MUTO FREDERICK T · CIK 0001181560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
MUTO FREDERICK TDirector
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000142 · edgardoc.xml · nonDerivative · entry 2 MUTO FREDERICK T · CIK 0001181560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
MUTO FREDERICK TDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000142 · edgardoc.xml · nonDerivative · entry 1 MUTO FREDERICK T · CIK 0001181560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
LOSCALZO JOSEPHDirector · Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000141 · edgardoc.xml · derivative · entry 4 LOSCALZO JOSEPH · CIK 0001276128 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F5 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F5 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
LOSCALZO JOSEPHDirector · Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000141 · edgardoc.xml · derivative · entry 3 LOSCALZO JOSEPH · CIK 0001276128 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
LOSCALZO JOSEPHDirector · Director
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000141 · edgardoc.xml · nonDerivative · entry 2 LOSCALZO JOSEPH · CIK 0001276128 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:21 UTC |
LOSCALZO JOSEPHDirector · Director
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000141 · edgardoc.xml · nonDerivative · entry 1 LOSCALZO JOSEPH · CIK 0001276128 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Hayden Michael RDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,777 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000138 · edgardoc.xml · derivative · entry 4 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 Underlying: Common Stock · 1,777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Hayden Michael RDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000138 · edgardoc.xml · derivative · entry 3 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,664 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Stock | 1,777 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000138 · edgardoc.xml · nonDerivative · entry 2 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000138 · edgardoc.xml · nonDerivative · entry 1 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · derivative · entry 8 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F9 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F9 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · derivative · entry 7 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F8 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F8 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
SaleCommon Stock | 644 | $38.78 | $24,974.32 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · nonDerivative · entry 4 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,791 F3 · kind: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. F3 · shares: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.44 to $39.23 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) on this Form 4. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
SaleCommon Stock | 689 | $37.74 | $26,002.86 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · nonDerivative · entry 3 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,435 F3 · kind: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. F3 · shares: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $38.225 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · nonDerivative · entry 2 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
KLEIN JOSEPH IIIDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000140 · edgardoc.xml · nonDerivative · entry 1 KLEIN JOSEPH III · CIK 0001206369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
HERMAN JOAN EDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,777 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000139 · edgardoc.xml · derivative · entry 4 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,665 Underlying: Common Stock · 1,777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
HERMAN JOAN EDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000139 · edgardoc.xml · derivative · entry 3 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
HERMAN JOAN EDirector
|
Exercise / conversionCommon Stock | 1,777 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000139 · edgardoc.xml · nonDerivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
HERMAN JOAN EDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000139 · edgardoc.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Diaz Allene M.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000137 · edgardoc.xml · derivative · entry 2 Diaz Allene M. · CIK 0001773314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 8,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC |
Diaz Allene M.Director
|
Exercise / conversionCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000137 · edgardoc.xml · nonDerivative · entry 1 Diaz Allene M. · CIK 0001773314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:19 UTC |
BERTHELSEN SPENCER RDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000136 · edgardoc.xml · derivative · entry 5 BERTHELSEN SPENCER R · CIK 0001181548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 2,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F6 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F6 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:19 UTC |
BERTHELSEN SPENCER RDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000136 · edgardoc.xml · derivative · entry 4 BERTHELSEN SPENCER R · CIK 0001181548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F5 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F5 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:19 UTC |
BERTHELSEN SPENCER RDirector
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000136 · edgardoc.xml · nonDerivative · entry 2 BERTHELSEN SPENCER R · CIK 0001181548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. F2 · shares: Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 23:19 UTC |
BERTHELSEN SPENCER RDirector
|
Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000136 · edgardoc.xml · nonDerivative · entry 1 BERTHELSEN SPENCER R · CIK 0001181548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:26 UTC |
WENDER JOSEPH HDirector
|
GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000126 · edgardoc.xml · derivative · entry 2 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,108 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. F3 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:26 UTC |
WENDER JOSEPH HDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $38.06 | $0.00 |
DisclosureSEC source: 0000874015-22-000126 · edgardoc.xml · derivative · entry 1 WENDER JOSEPH H · CIK 0001073384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. F1 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:26 UTC |
PARSHALL B LYNNEDirector
|
GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000125 · edgardoc.xml · derivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,108 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. F3 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:26 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $38.06 | $0.00 |
DisclosureSEC source: 0000874015-22-000125 · edgardoc.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. F1 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:25 UTC |
MUTO FREDERICK TDirector
|
GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000124 · edgardoc.xml · derivative · entry 5 MUTO FREDERICK T · CIK 0001181560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,108 Underlying: Common Stock · 5,333 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. F4 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.